메뉴 건너뛰기




Volumn 58, Issue 2, 2006, Pages 209-218

Synthesis and binding profile of constrained analogues of N-[4-(4-arylpiperazin-1-yl)butyl]-3-methoxybenzamides, a class of potent dopamine D3 receptor ligands

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; DOPAMINE 3 RECEPTOR STIMULATING AGENT; GUANOSINE TRIPHOSPHATE; N [4 [4 (2,3 DICHLOROPHENYL) 1 PIPERAZINYL]CYCLOHEXYL] 3 METHOXYBENZAMIDE; UNCLASSIFIED DRUG;

EID: 31544444193     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.2.0008     Document Type: Article
Times cited : (13)

References (19)
  • 2
    • 0036170920 scopus 로고    scopus 로고
    • A review of pramipexole and its clinical utility in Parkinson's disease
    • Biglan, K. M., Holloway, R. G. (2002) A review of pramipexole and its clinical utility in Parkinson's disease. Expert Opin. Pharmacother. 3: 197-210
    • (2002) Expert Opin. Pharmacother. , vol.3 , pp. 197-210
    • Biglan, K.M.1    Holloway, R.G.2
  • 7
    • 0018835131 scopus 로고
    • α-adrenoceptors in rat brain: Sodium changes the affinity of agonists for prazosin sites
    • Glossmann, H., Hornung, R. (1980) α-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. Eur. J. Pharmacol. 61: 407-408
    • (1980) Eur. J. Pharmacol. , vol.61 , pp. 407-408
    • Glossmann, H.1    Hornung, R.2
  • 8
    • 0037019828 scopus 로고    scopus 로고
    • 3 receptor ligands with antagonistic properties
    • 3 receptor ligands with antagonistic properties. ChemBioChem 3: 946-961
    • (2002) ChemBioChem , vol.3 , pp. 946-961
    • Hackling, A.E.1    Stark, H.2
  • 11
    • 0030610305 scopus 로고    scopus 로고
    • 3 dopamine receptor: Neurobiology and potential clinical relevance
    • 3 dopamine receptor: neurobiology and potential clinical relevance. Pharmacol. Rev. 49: 231-252
    • (1997) Pharmacol. Rev. , vol.49 , pp. 231-252
    • Levant, B.1
  • 12
    • 0037278185 scopus 로고    scopus 로고
    • 3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders
    • 3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders. Curr. Pharm. Des. 9: 643-671
    • (2003) Curr. Pharm. Des. , vol.9 , pp. 643-671
    • Luedtke, R.R.1    Mach, R.H.2
  • 15
    • 0030043026 scopus 로고    scopus 로고
    • Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivatives
    • Norman, M. H., Minick, D. J., Rigdon, G. C. (1996) Effect of linking bridge modifications on the antipsychotic profile of some phthalimide and isoindolinone derivatives. J. Med. Chem. 39: 149-157
    • (1996) J. Med. Chem. , vol.39 , pp. 149-157
    • Norman, M.H.1    Minick, D.J.2    Rigdon, G.C.3
  • 16
    • 37049150114 scopus 로고
    • Aryl-2-haloalkylamines. I
    • Ross, W. C. J. (1949) Aryl-2-haloalkylamines. I. J. Chem. Soc. 183-191
    • (1949) J. Chem. Soc. , pp. 183-191
    • Ross, W.C.J.1
  • 19
    • 0035919534 scopus 로고    scopus 로고
    • The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors
    • Wicke, K., Javier Garcia-Ladona, J. (2001) The dopamine D3 receptor partial agonist, BP 897, is an antagonist at human dopamine D3 receptors and at rat somatodendritic dopamine D3 receptors. Eur. J. Pharmacol. 424: 85-90
    • (2001) Eur. J. Pharmacol. , vol.424 , pp. 85-90
    • Wicke, K.1    Javier Garcia-Ladona, J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.